What changed
Added the source-verified Claim Check to the structured claim/source/change registry.
Source record · FDA evidence review and preclinical study · reviewed July 18, 2026
KPV has preclinical signals. A clinically proven human benefit has not been established.
The circulating claim“KPV is clinically proven for inflammation, gut problems, and wound healing.”
What the source record says
Cell and mouse studies report anti-inflammatory signals, but FDA's 2026 review says it identified no KPV clinical studies or human exposure data through any route. Preclinical findings cannot establish a human treatment effect.
Why the claim misleads
A mechanism and animal-model result are being described as clinical proof even though human administration and outcomes have not been established.
Correction
KPV has preclinical signals. A clinically proven human benefit has not been established.
Primary sources
FDA KPV briefing document, 2026Open source ↗Dalmasso et al., 2008 — cell and mouse colitis studyOpen source ↗KPV library entryOpen source ↗What would change our answer
A well-controlled human study tied to the exact product, population, route, and claimed outcome could change the answer. Mechanism, anecdotes, or a different product cannot substitute for that evidence.
Version history · 1 entry
- v1 · 2026-07-18Initial structured record created from the reviewed Claim Check.Source ↗
Boundary: This check evaluates a public claim. It does not assess an individual product or person and is not treatment, dosing, sourcing, or legal advice.